Achmad A, Bhattarai A, Yudistiro R, Heryanto YD, Higuchi T, Tsushima Y (2017) The diagnostic performance of 18 F-FAMT PET and 18 F-FDG PET for malignancy detection: a meta-analysis. BMC Med Imaging 17:66. https://doi.org/10.1186/s12880-017-0237-1
Article
PubMed
PubMed Central
Google Scholar
Aihara T, Hiratsuka J, Kamitani N, Nishimura H, Ono K (2020) Boron neutron capture therapy for head and neck cancer: relevance of nuclear-cytoplasmic volume ratio and anti-tumor effect. A Preliminary Report. Appl Radiat Isot 163:109212. https://doi.org/10.1016/j.apradiso.2020.109212
Article
CAS
PubMed
Google Scholar
Bertagna F, Nicolai P, Maroldi R, Mattavelli D, Bertoli M, Giubbini R et al (2015) Diagnostic role of 18F-FDG-PET or PET/CT in salivary gland tumors: a systematic review. Rev Esp Med Nucl Imagen Mol 34:295–302
CAS
PubMed
Google Scholar
Beshr R, Isohashi K, Watabe T, Naka S, Horitsugi G, Romanov V et al (2018) Preliminary feasibility study on differential diagnosis between radiation-induced cerebral necrosis and recurrent brain tumor by means of [18F]fluoro-borono-phenylalanine PET/CT. Ann Nucl Med 32:702–708. https://doi.org/10.1007/s12149-018-1296-2
Article
PubMed
Google Scholar
Chen H, Pang Y, Wu J, Zhao L, Hao B, Wu J et al (2020) Comparison of [68Ga] Ga-DOTA-FAPI-04 and [1F] FDG PET/CT for the diagnosis of primary and metastatic lesions in patients with various types of cancer. Eur J Nucl Med Mol Imaging 47:1820–1822. https://doi.org/10.1007/s00259-020-04769-z
Article
PubMed
Google Scholar
Fu L, Huang S, Wu H, Dong Y, Xie F, Wu R et al (2022) Superiority of [68Ga] Ga-FAPI-04/[18F] FAPI-42 PET/CT to [18F] FDG PET/CT in delineating the primary tumor and peritoneal metastasis in initial gastric cancer. Eur Radiol 32(9):6281–6290. https://doi.org/10.1007/s00330-022-08743-1
Article
CAS
PubMed
Google Scholar
Furuse M, Nonoguchi N, Yamada K, Shiga T, Combes JD, Ikeda N et al (2019) Radiological diagnosis of brain radiation necrosis after cranial irradiation for brain tumor: a systematic review. Radiat Oncol 14:28. https://doi.org/10.1186/s13014-019-1228-x
Article
PubMed
PubMed Central
Google Scholar
Hanaoka K, Watabe T, Naka S, Kanai Y, Ikeda H, Horitsugi G et al (2014) FBPA PET in boron neutron capture therapy for cancer: prediction of (10)B concentration in the tumor and normal tissue in a rat xenograft model. EJNMMI Res 4:70. https://doi.org/10.1186/s13550-014-0070-2
Article
CAS
PubMed
PubMed Central
Google Scholar
Hatazawa J, Higuchi I, Nakamura H (2003) Positron emission tomography in oncology. Gan to Kagaku Ryoho 30:748–754
PubMed
Google Scholar
Igaki H, Nakamura S, Kurihara H, Abe Y, Nishioka S, Fujii R et al (2020) Comparison of 18FBPA uptake with 18FDG uptake in cancer patients. Appl Radiat Isot 157:109019. https://doi.org/10.1016/j.apradiso.2019.109019
Article
CAS
PubMed
Google Scholar
Imahori Y, Ueda S, Ohmori Y, Kusuki T, Ono K, Fujii R et al (1998) Fluorine-18-labeled fluoroboronophenylalanine PET in patients with glioma. J Nucl Med 39(2):325–333
CAS
PubMed
Google Scholar
Inoue T, Koyama K, Oriuchi N, Alyafei S, Yuan Z, Suzuki H et al (2001) Detection of malignant tumors: whole-body PET with fluorine 18 α-methyl tyrosine versus FDG - preliminary study. Radiology 220:54–62. https://doi.org/10.1148/radiology.220.1.r01jl1654
Article
CAS
PubMed
Google Scholar
Ishiwata K (2019) 4-Borono-2-18F-fluoro-L-phenylalanine PET for boron neutron capture therapy-oriented diagnosis: overview of a quarter century of research. Ann Nucl Med 33:223–236. https://doi.org/10.1007/s12149-019-01347-8
Article
CAS
PubMed
PubMed Central
Google Scholar
Ishiwata K, Ido T, Mejia AA, Ichihashi M, Mishima Y (1991) Synthesis and radiate on dosimetry of 4-borono-2-[18F]fluoro-D, L-phenylalanine: a target compound for PET and boron neutron capture therapy. Int J Rad Appl Instrum A 42:325–328. https://doi.org/10.1016/0883-2889(91)90133-l
Article
CAS
PubMed
Google Scholar
Isoda A, Kaira K, Iwashina M, Oriuchi N, Tominaga H, Nagamori S et al (2014) Expression of L-type amino acid transporter 1 (LAT1) as a prognostic and therapeutic indicator in multiple myeloma. Cancer Sci 105(11):1496–1502. https://doi.org/10.1111/cas.12529
Article
CAS
PubMed
PubMed Central
Google Scholar
Isohashi K, Tatsumi M, Higuchi I, Inoue A, Nakajo K, Ishikawa J et al (2008) 18F-FDG-PET in patients with malignant lymphoma having long-term follow-up: staging and restaging, and evaluation of treatment response and recurrence. Ann Nucl Med 22:795–802. https://doi.org/10.1007/s12149-008-0186-4
Article
PubMed
Google Scholar
Isohashi K, Shimosegawa E, Kato H, Kanai Y, Naka S, Fujino K et al (2013) Optimization of [11C]methionine PET study: appropriate scan timing and effect of plasma amino acid concentrations on the SUV. EJNMMI Res 3(1):27. https://doi.org/10.1186/2191-219X-3-27
Article
CAS
PubMed
PubMed Central
Google Scholar
Isohashi K, Shimosegawa E, Naka S, Kanai Y, Horitsugi G, Mochida I et al (2016) Comparison of the image-derived radioactivity and blood-sample radioactivity for estimating the clinical indicators of the efficacy of boron neutron capture therapy (BNCT): 4-borono-2-18F-fluoro-phenylalanine (FBPA) PET study. EJNMMI Res 6:75. https://doi.org/10.1186/s13550-016-0230-7
Article
CAS
PubMed
PubMed Central
Google Scholar
Kaira K, Oriuchi N, Otani Y, Yanagitani N, Sunaga N, Hisada T et al (2007) Diagnostic usefulness of fluorine-18-alpha-methyltyrosine positron emission tomography in combination with 18F-fluorodeoxyglucose in sarcoidosis patients. Chest 131:1019–1027. https://doi.org/10.1378/chest.06-2160
Article
PubMed
Google Scholar
Kaira K, Oriuchi N, Imai H, Shimizu K, Yanagitani N, Sunaga N et al (2009) Prognostic significance of L-type amino acid transporter 1 (LAT1) and 4F2 heavy chain (CD98) expression in stage I pulmonary adenocarcinoma. Lung Cancer 66(1):120–126. https://doi.org/10.1016/j.lungcan.2008.12.015
Article
PubMed
Google Scholar
Kaira K, Sunose Y, Arakawa K, Ogawa T, Sunaga N, Shimizu K et al (2012) Prognostic significance of L-type amino-acid transporter 1 expression in surgically resected pancreatic cancer. Br J Cancer 107(4):632–638. https://doi.org/10.1038/bjc.2012.310
Article
CAS
PubMed
PubMed Central
Google Scholar
Kaira K, Sunose Y, Ohshima Y, Ishioka NS, Arakawa K, Ogawa T et al (2013) Clinical significance of L-type amino acid transporter 1 expression as a prognostic marker and potential of new targeting therapy in biliary tract cancer. BMC Cancer 13:482. https://doi.org/10.1186/1471-2407-13-482
Article
PubMed
PubMed Central
Google Scholar
Kanai Y (2022) Amino acid transporter LAT1 (SLC7A5) as a molecular target for cancer diagnosis and therapeutics. Pharmacol Ther 230:107964. https://doi.org/10.1016/j.pharmthera.2021.107964
Article
CAS
PubMed
Google Scholar
Kato I, Fujita Y, Maruhashi A, Kumada H, Ohmae M, Kirihata M et al (2009) Effectiveness of boron neutron capture therapy for recurrent head and neck malignancies. Appl Radiat Isot 67:S37-42. https://doi.org/10.1016/j.apradiso.2009.03.103
Article
CAS
PubMed
Google Scholar
Khunweeraphong N, Nagamori S, Wiriyasermkul P, Nishinaka Y, Wongthai P, Ohgaki R et al (2012) Establishment of stable cell lines with high expression of heterodimers of human 4F2hc and human amino acid transporter LAT1 or LAT2 and delineation of their differential interaction with α-alkyl moieties. J Pharmacol Sci 119:368–380. https://doi.org/10.1254/jphs.12124fp
Article
CAS
PubMed
PubMed Central
Google Scholar
Kim M, Achmad A, Higuchi T, Arisaka Y, Yokoo H, Yokoo S et al (2015) Effects of intratumoral inflammatory process on 18F-FDG uptake: pathologic and comparative study with 18F-fluoro-α-methyltyrosine PET/CT in oral squamous cell carcinoma. J Nucl Med 56:16–21. https://doi.org/10.2967/jnumed.114.144014
Article
CAS
PubMed
Google Scholar
Kinoshita M, Arita H, Goto T, Okita Y, Isohashi K, Watabe T et al (2012) A novel PET index, 18F-FDG-11C-methionine uptake decoupling score, reflects glioma cell infiltration. J Nucl Med 53:1701–1708. https://doi.org/10.2967/jnumed.112.104992
Article
PubMed
Google Scholar
Kozal K, Jóźwiak P, Krześlak A (2021) Contemporary perspectives on the Warburg effect inhibition in cancer therapy. Cancer Control 28:10732748211041244. https://doi.org/10.1177/10732748211041243
Article
PubMed
PubMed Central
Google Scholar
Kratochwil C, Flechsig P, Lindner T, Abderrahim L, Altmann A, Mier W et al (2019) 68Ga-FAPI PET/CT: tracer uptake in 28 different kinds of cancer. J Nucl Med 60:801–805. https://doi.org/10.2967/jnumed.119.227967
Article
CAS
PubMed
PubMed Central
Google Scholar
Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T (1992) Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 33:1972–1980
CAS
PubMed
Google Scholar
Kubota R, Kubota K, Yamada S, Tada M, Ido T, Tamahashi N (1994) Microautoradiographic study for the differentiation of intratumoral macrophages, granulation tissues and cancer cells by the dynamics of fluorine-18-fluorodeoxyglucose uptake. J Nucl Med 35:104–112
CAS
PubMed
Google Scholar
Lu JJ, Li P, Yang Y, Wang L, Zhang Y, Zhu JY et al (2020) Prognostic value of LAT-1 status in solid cancer: a systematic review and meta-analysis. PLoS ONE 15(5):e0233629. https://doi.org/10.1371/journal.pone.0233629
Article
CAS
PubMed
PubMed Central
Google Scholar
Miyashita M, Miyatake S, Imahori Y, Yokoyama K, Kawabata S, Kajimoto Y et al (2008) Evaluation of fluoride-labeled boronophenylalanine-PET imaging for the study of radiation effects in patients with glioblastomas. J Neurooncol 89:239–246. https://doi.org/10.1007/s11060-008-9621-6
Article
PubMed
Google Scholar
Oda H (2014) Amino acid metabolism in cancer cells. Seikagaku 86:332–337
CAS
PubMed
Google Scholar
Ono K, Tanaka H, Tamari Y, Watanabe T, Suzuki M, Masunaga SI (2019) Proposal for determining absolute biological effectiveness of boron neutron capture therapy-the effect of 10B(n, α)7Li dose can be predicted from the nucleocytoplasmic ratio or the cell size. J Radiat Res 60:29–36. https://doi.org/10.1093/jrr/rry080
Article
CAS
PubMed
Google Scholar
Plaxton NA, Brandon DC, Corey AS, Harrison CE, Karagulle Kendi AT, Halkar RK et al (2015) Characteristics and limitations of FDG PET/CT for imaging of squamous cell carcinoma of the head and neck: a comprehensive review of anatomy, metastatic pathways, and image findings. AJR Am J Roentgenol 205:W519–W531. https://doi.org/10.2214/AJR.14.12828
Article
PubMed
Google Scholar
Romanov V, Isohashi K, Alobthani G, Beshr R, Horitsugi G, Kanai Y et al (2020) Evaluation of the total distribution volume of 18F-FBPA in normal tissues of healthy volunteers by non-compartmental kinetic modeling. Ann Nucl Med 34:155–162. https://doi.org/10.1007/s12149-019-01427-9
Article
CAS
PubMed
Google Scholar
Shimizu A, Kaira K, Kato M, Yasuda M, Takahashi A, Tominaga H et al (2015) Prognostic significance of L-type amino acid transporter 1 (LAT1) expression in cutaneous melanoma. Melanoma Res 25(5):399–405. https://doi.org/10.1097/CMR.0000000000000181
Article
CAS
PubMed
Google Scholar
Shimosegawa E, Isohashi K, Naka S, Horitsugi G, Hatazawa J (2016) Assessment of 10B concentration in boron neutron capture therapy: potential of image-guided therapy using 18FBPA PET. Ann Nucl Med 30:749–755. https://doi.org/10.1007/s12149-016-1121-8
Article
CAS
PubMed
Google Scholar
Tang R, Wang JT, Wang L, Le K, Huang Y, Hickey AJ et al (2016) Impact of patient preparation on the diagnostic performance of 18F-FDG PET in cardiac sarcoidosis: a systematic review and meta-analysis. Clin Nucl Med 41:e327–e339. https://doi.org/10.1097/RLU.0000000000001063
Article
PubMed
Google Scholar
van der Geest KSM, Treglia G, Glaudemans AWJM, Brouwer E, Sandovici M, Jamar F et al (2021) Diagnostic value of [18F] FDG-PET/CT for treatment monitoring in large vessel vasculitis: a systematic review and meta-analysis. Eur J Nucl Med Mol Imaging 48:3886–3902. https://doi.org/10.1007/s00259-021-05362-8
Article
PubMed
PubMed Central
Google Scholar
Watabe T, Ikeda H, Nagamori S, Wiriyasermkul P, Tanaka Y, Naka S et al (2017) 18F-FBPA as a tumor-specific probe of L-type amino acid transporter 1 (LAT1): a comparison study with 18F-FDG and 11C-methionine PET. Eur J Nucl Med Mol Imaging 44:321–331. https://doi.org/10.1007/s00259-016-3487-1
Article
CAS
PubMed
Google Scholar
Wedman J, Pruim J, Putten L, Hoekstra OS, Bree R, Dijk BAC et al (2019) Is C-11 Methionine PET an alternative to 18-F FDG-PET for identifying recurrent laryngeal cancer after radiotherapy? Clin Otolaryngol 44(2):124–130. https://doi.org/10.1111/coa.13242
Article
PubMed
Google Scholar
Wei L, Tominaga H, Ohgaki R, Wiriyasermkul P, Hagiwara K, Okuda S et al (2016) Specific transport of 3-fluoro-l-α-methyl-tyrosine by LAT1 explains its specificity to malignant tumors in imaging. Cancer Sci 107:347–352. https://doi.org/10.1111/cas.12878
Article
CAS
PubMed
PubMed Central
Google Scholar
Wiriyasermkul P, Moriyama S, Kongpracha P, Nagamori S (2021) Drug discovery targeting an amino acid transporter for diagnosis and therapy. Yakugaku Zasshi 141(4):501–510. https://doi.org/10.1248/yakushi.20-00204-2
Article
CAS
PubMed
Google Scholar
Wongthai P, Hagiwara K, Miyoshi Y, Wiriyasermkul P, Wei L, Ohgaki R et al (2015) Boronophenylalanine, a boron delivery agent for boron neutron capture therapy, is transported by ATB0,+, LAT1 and LAT2. Cancer Sci 106:279–286. https://doi.org/10.1111/cas.12602
Article
CAS
PubMed
PubMed Central
Google Scholar
Yamada S, Kubota K, Kubota R, Ido T, Tamahashi N (1995) High accumulation of fluorine-18-fluorodeoxyglucose in turpentine-induced inflammatory tissue. J Nucl Med 36:1301–1306
CAS
PubMed
Google Scholar
Yoshimoto M, Kurihara H, Honda N, Kawai K, Ohe K, Fujii H et al (2013) Predominant contribution of L-type amino acid transporter to 4-borono-2-(18)F-fluoro-phenylalanine uptake in human glioblastoma cells. Nucl Med Biol 40(5):625–629. https://doi.org/10.1016/j.nucmedbio.2013.02.010
Article
CAS
PubMed
Google Scholar